Malignant Post-Transplant Lymphoproliferative Disorder of Nasopharynx in Myelodysplastic Disorder.
Chih-Wei LuanChih-Cheng ChenKam-Fai LeeMing-Shao TsaiYao-Te TsaiCheng-Ming HsuGeng-He ChangPublished in: Healthcare (Basel, Switzerland) (2021)
(1) Background: Post-transplant lymphoproliferative disorder (PTLD) is a hematological disease and occurs because of immunosuppression after organ transplantation. Only a few studies have reported PTLD in the nasopharynx. In most cases, PTLD developed after solid organ transplantation, and cases of PTLD after bone marrow transplantation, are uncommon. (2) Case presentation: We report the case of a 40-year-old woman with myelodysplastic disorder who underwent hematopoietic stem cell transplantation (HSCT). After 3 months, she developed low-grade fever, progressive nasal obstruction, and bloody rhinorrhea. Endoscopy revealed a mass completely occupying the nasopharynx. A polymorphic PTLD was diagnosed on the basis of histopathological examination results. Reduction in immunosuppression and low-dose radiotherapy were prescribed for treatment. After a 3-year follow-up, no recurrence of PTLD or myelodysplastic disorder was detected. (3) Conclusions: While nasopharyngeal PTLD is rare, a routine examination of the nasopharynx should be considered in the post-transplant follow-up of patients for early detection and treatment of PTLD.
Keyphrases
- bone marrow
- acute myeloid leukemia
- low grade
- low dose
- end stage renal disease
- epstein barr virus
- mesenchymal stem cells
- high grade
- early stage
- ejection fraction
- newly diagnosed
- multiple sclerosis
- chronic kidney disease
- radiation therapy
- stem cells
- peritoneal dialysis
- prognostic factors
- high dose
- locally advanced
- combination therapy
- patient reported outcomes
- case control